Physician profile
Richard Wayne Bennett
NPI 1407871510
$4,973.43
in general payments reported to CMS, 2019-2025
41 companies · $677 in 2025
The $677 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,513 · 2020: $181 · 2021: $369 · 2022: $535 · 2023: $358 · 2024: $341 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,375.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $827.58 | 2019-2025 | Qulipta, Vraylar, Ubrelvy |
| Amgen INC. | $580.37 | 2019-2025 | Evenity, Repatha, Prolia |
| Pfizer INC. | $439.77 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $329.00 | 2019-2024 | Jardiance, Tradjenta, Synjardy |
| Janssen Pharmaceuticals, INC | $268.57 | 2019-2023 | Spravato |
| Novo Nordisk INC | $266.28 | 2019-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $201.32 | 2019-2023 | Breztri |
| Allergan, INC. | $177.92 | 2019 | |
| Glaxosmithkline, LLC. | $167.43 | 2019-2025 | Shingrix |
| Novartis Pharmaceuticals Corporation | $166.55 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $149.53 | 2019-2025 | |
| Abbott Laboratories | $140.48 | 2019-2024 | Freestyle Libre 3 |
| Lilly USA, LLC | $108.88 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| E.R. Squibb & Sons, L.L.C. | $108.20 | 2019-2025 | Camzyos |
| Boston Scientific Corporation | $102.04 | 2019-2025 | Watchman Flx |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.